Foetal lipoprotein oxidation and preeclampsia

Abstract Preeclampsia (PE) is a multisystemic syndrome specific to pregnancy. Although PE is the leading cause of death from complications associated with pregnancy, its aetiology is still unknown. In PE, lipid metabolism is altered. When lipids are damaged, both the mother and the foetus may be at...

Full description

Bibliographic Details
Main Authors: LA Gil-Acevedo, Guillermo Ceballos, YD Torres-Ramos
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-022-01663-5
_version_ 1818161928966504448
author LA Gil-Acevedo
Guillermo Ceballos
YD Torres-Ramos
author_facet LA Gil-Acevedo
Guillermo Ceballos
YD Torres-Ramos
author_sort LA Gil-Acevedo
collection DOAJ
description Abstract Preeclampsia (PE) is a multisystemic syndrome specific to pregnancy. Although PE is the leading cause of death from complications associated with pregnancy, its aetiology is still unknown. In PE, lipid metabolism is altered. When lipids are damaged, both the mother and the foetus may be at risk. Lipoproteins contain apolipoproteins, triacylglycerols, free and esterified cholesterol, and phospholipids, all of which are susceptible to oxidative stress when high levels of oxygen and nitrogen free radicals are present. Lipoperoxidation can occur in three stages: mild, moderate, and severe. In severe lipid damage, highly toxic products such as malondialdehyde (MDA) can be generated; under these conditions, low-density lipoprotein (LDL) proteins can be oxidized (oxLDL). oxLDL is a biomolecule that can affect the production of nitric oxide (NO), the main vasodilator derived from the endothelium. oxLDL can interfere with the transduction of the signals responsible for triggering the activation of endothelial nitric oxide synthase (eNOS), causing reduced vasodilation and endothelial dysfunction, which are the main characteristics of preeclampsia. The objective of the review was to analyse the information the current information about exists about the impact generated by the oxidation of LDL and HDL lipoproteins in neonates of women with preeclampsia and how these alterations can predispose the neonate to develop diseases in adulthood. PE can cause foetal loss, intrauterine growth restriction, or developmental complications. Neonates of mothers with PE have a high risk of cardiovascular diseases, stroke, mental retardation, sensory deficiencies and an increased risk of developing metabolic diseases. PE not only affects the foetus, generating complications during pregnancy but also predisposes them to chronic diseases in adulthood.
first_indexed 2024-12-11T16:25:34Z
format Article
id doaj.art-843a55804b7c4ec88cc3d7512ebd2857
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-12-11T16:25:34Z
publishDate 2022-06-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-843a55804b7c4ec88cc3d7512ebd28572022-12-22T00:58:45ZengBMCLipids in Health and Disease1476-511X2022-06-012111910.1186/s12944-022-01663-5Foetal lipoprotein oxidation and preeclampsiaLA Gil-Acevedo0Guillermo Ceballos1YD Torres-Ramos2Laboratorio Central, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Secretaría de SaludLaboratorio de Investigación Integral Cardiometabólica, Escuela Superior de Medicina, Instituto Politécnico NacionalDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los ReyesAbstract Preeclampsia (PE) is a multisystemic syndrome specific to pregnancy. Although PE is the leading cause of death from complications associated with pregnancy, its aetiology is still unknown. In PE, lipid metabolism is altered. When lipids are damaged, both the mother and the foetus may be at risk. Lipoproteins contain apolipoproteins, triacylglycerols, free and esterified cholesterol, and phospholipids, all of which are susceptible to oxidative stress when high levels of oxygen and nitrogen free radicals are present. Lipoperoxidation can occur in three stages: mild, moderate, and severe. In severe lipid damage, highly toxic products such as malondialdehyde (MDA) can be generated; under these conditions, low-density lipoprotein (LDL) proteins can be oxidized (oxLDL). oxLDL is a biomolecule that can affect the production of nitric oxide (NO), the main vasodilator derived from the endothelium. oxLDL can interfere with the transduction of the signals responsible for triggering the activation of endothelial nitric oxide synthase (eNOS), causing reduced vasodilation and endothelial dysfunction, which are the main characteristics of preeclampsia. The objective of the review was to analyse the information the current information about exists about the impact generated by the oxidation of LDL and HDL lipoproteins in neonates of women with preeclampsia and how these alterations can predispose the neonate to develop diseases in adulthood. PE can cause foetal loss, intrauterine growth restriction, or developmental complications. Neonates of mothers with PE have a high risk of cardiovascular diseases, stroke, mental retardation, sensory deficiencies and an increased risk of developing metabolic diseases. PE not only affects the foetus, generating complications during pregnancy but also predisposes them to chronic diseases in adulthood.https://doi.org/10.1186/s12944-022-01663-5LipoproteinsOxidative damagePreeclampsiaFoetal programming
spellingShingle LA Gil-Acevedo
Guillermo Ceballos
YD Torres-Ramos
Foetal lipoprotein oxidation and preeclampsia
Lipids in Health and Disease
Lipoproteins
Oxidative damage
Preeclampsia
Foetal programming
title Foetal lipoprotein oxidation and preeclampsia
title_full Foetal lipoprotein oxidation and preeclampsia
title_fullStr Foetal lipoprotein oxidation and preeclampsia
title_full_unstemmed Foetal lipoprotein oxidation and preeclampsia
title_short Foetal lipoprotein oxidation and preeclampsia
title_sort foetal lipoprotein oxidation and preeclampsia
topic Lipoproteins
Oxidative damage
Preeclampsia
Foetal programming
url https://doi.org/10.1186/s12944-022-01663-5
work_keys_str_mv AT lagilacevedo foetallipoproteinoxidationandpreeclampsia
AT guillermoceballos foetallipoproteinoxidationandpreeclampsia
AT ydtorresramos foetallipoproteinoxidationandpreeclampsia